Dr. John Mendelsohn’s Legacy and the Future of Cancer Research

Dr. John Mendelsohn (1936-2019) impacted health care, cancer research and the future of Texas through his work as a physician-scientist, as president of The University of Texas MD Anderson Cancer Center and as an advocate for cancer research. This event honored Mendelsohn’s achievements and their impact on the future of cancer research.

A panel moderated by Dr. Peter W.T. Pisters, president of MD Anderson, explored Mendelsohn’s research, his role as the president of MD Anderson and his work as an advocate for cancer research and innovation. Panelists also discussed Mendelsohn’s scientific work and his contributions to and leadership of the MD Anderson Institute for Personalized Cancer Therapy, which represents Mendelsohn’s vision for the future of cancer treatment, as well as Mendelsohn’s efforts to promote public health and cancer research policies at the state and national levels, including the creation of the Cancer Prevention and Research Institute of Texas.

This event was part of the Medicine, Research and Society Policy Issues Series, a joint project between the Baker Institute Center for Health and Biosciences and The University of Texas MD Anderson Cancer Center. Additional support was provided by the American Academy of Arts and Sciences.

Follow @BakerInstitute on Twitter and join the conversation online with #BakerHealth.